Pierre Mourier
12Patents
2h-index
8Co-inventors
43Inventor score
Filing activity: Oct 20, 2000 → Apr 11, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6617316B1 | Oligosaccharides, their preparation and pharmaceutical compositions containing them | Chemistry; Metallurgy | 23 | Expired |
| US6608042B2 | Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof | Chemistry; Metallurgy | 2 | Expired |
| US8071570B2 | Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them | Human Necessities | 1 | Active |
| US8003623B2 | Mixtures of sulfated oligosaccharides | Human Necessities | 1 | Active |
| US7575930B2 | Method for analyzing oligosaccharides from blood plasma | Emerging Cross-Sectional Technologies | 1 | Active |
| US8518909B2 | Sulfated heptasaccharide and its use as an antithrombotic agent | Human Necessities | 0 | Active |
| US8608961B2 | Method for affinity chromatography of antithrombin III | Performing Operations; Transporting | 0 | Active |
| US8501711B2 | Acylated 1,6-anhydro decasaccharide and its use as an antithrombotic agent | Human Necessities | 0 | Active |
| US8546354B2 | Acylated decasaccharides and their use as antithrombotic agents | Human Necessities | 0 | Active |
| US7956046B2 | Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them | Human Necessities | 0 | Expired |
| US7687274B2 | Method for determining specific groups constituting heparins or low molecular weight heparins | Emerging Cross-Sectional Technologies | 0 | Active |
| US9346894B2 | Polysaccharides comprising two antithrombin III-binding sites, preparation thereof and use thereof as antithrombotic medicaments | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.